组别

n

CD3+ (%)

CD4+ (%)

CD8+ (%)

CD4+/CD8+ (%)

治疗前

治疗后

治疗前

治疗后

治疗前

治疗后

治疗前

治疗后

研究组

30

62.74 ± 6.54

76.61 ± 8.17

33.02 ± 5.14

43.31 ± 5.91

27.56 ± 5.84

24.2 ± 5.29

1.07 ± 0.29

1.68 ± 0.41

对照组

30

62.81 ± 6.21

68.42 ± 6.68

33.09 ± 5.13

36.99 ± 5.29

26.98 ± 5.89

25.1 ± 5.14

1.05 ± 0.33

1.30 ± 0.32

t

0.186

5.623

0.268

6.832

0.013

0.523

1.184

4.763

p

0.825

0.000

0.725

0.000

0.965

0.600

0.215

0.000